CARDIFF ONCOLOGY INC shareholders Q2 2023

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 54 filers reported holding CARDIFF ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

CARDIFF ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 48,739$71,6460.00%
Newbridge Financial Services Group, Inc. 115$1690.00%
JPMORGAN CHASE & CO 26$380.00%
Creative Planning 57,750$84,8930.00%
ROYAL BANK OF CANADA 19,299$28,0000.00%
NewSquare Capital LLC 125$1840.00%
Allworth Financial LP 100$1470.00%
VANGUARD GROUP INC 1,942,918$2,856,0890.00%
UBS Group AG 3,814$5,6060.00%
NewEdge Advisors, LLC 81$1190.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 48$710.00%
TWO SIGMA INVESTMENTS, LP 93,232$137,0510.00%
BerganKDV Wealth Management, LLC 1$20.00%
OSAIC HOLDINGS, INC. 1,565$2,3000.00%
FMR LLC 2,540$3,7340.00%
External links

This page lists CARDIFF ONCOLOGY INC's shareholders in Q2 2023. To view CARDIFF ONCOLOGY INC's shareholder history, click here.